Hematopoietic System--Cancer — Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
Citation(s)
Improved Post-Transplant Cyclophosphamide Regimens for Unmanipulated Haploidentical Transplant in Pediatric Patients With Refractory Acute Myeloid Leukemia